Bafna Pharmaceuticals Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|
| Revenue | 35.22 | 40.09 | 33.38 |
| Operating Expense | 29.56 | 37.74 | 30.14 |
| Net Profit | 3.39 | 1.31 | 0.95 |
| Net Profit Margin | 9.63 | 3.27 | 2.85 |
| Earning Per Share | 1.43 | 0.55 | 0.40 |
| EBIDTA | 5.67 | 2.35 | 3.25 |
| Effective Tax Rate | TBA | TBA | TBA |
| Particulars | Jun 2025 |
|---|---|
| Revenue | 35.22 |
| Operating Expense | 29.56 |
| Net Profit | 3.39 |
| Net Profit Margin | 9.63 |
| Earning Per Share | 1.43 |
| EBIDTA | 5.67 |
| Effective Tax Rate | TBA |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Total Revenue Annual | 145.86 | 152.47 | 115.35 |
| Operating Expenses Annual | 134.68 | 141.35 | 99.63 |
| Operating Profit Annual | 11.77 | 14.63 | 18.99 |
| Interest Annual | 2.73 | 2.29 | 2.04 |
| Depreciation | 4.89 | 5.00 | 5.33 |
| Net Profit Annual | 4.15 | 7.35 | 11.34 |
| Tax Annual | TBA | TBA | 0.28 |
| Particulars | Mar 2025 |
|---|---|
| Total Revenue Annual | 145.86 |
| Operating Expenses Annual | 134.68 |
| Operating Profit Annual | 11.77 |
| Interest Annual | 2.73 |
| Depreciation | 4.89 |
| Net Profit Annual | 4.15 |
| Tax Annual | TBA |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Cash Flow at the Beginning | 1.40 | 7.81 | 0.17 |
| Cash Flow from Operations | 22.14 | 9.48 | 4.95 |
| Cash Flow from Investing | -21.16 | -15.05 | -7.49 |
| Cash Flow from Financing | 1.06 | -0.85 | 10.18 |
| Cash Flow at the End | 3.43 | 1.40 | 7.81 |
| Particulars | Mar 2025 |
|---|---|
| Cash Flow at the Beginning | 1.40 |
| Cash Flow from Operations | 22.14 |
| Cash Flow from Investing | -21.16 |
| Cash Flow from Financing | 1.06 |
| Cash Flow at the End | 3.43 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| PBDIT Margin (%) | 9.59 | 9.60 | 16.46 |
| PBIT Margin (%) | 6.24 | 6.32 | 11.84 |
| PBT Margin (%) | 3.96 | 3.56 | 6.03 |
| Net PROFIT Margin (%) | 2.85 | 4.82 | 9.83 |
| Return On Networth / Equity (%) | 4.98 | 5.74 | 8.86 |
| Return On Networth /Employed (%) | 5.82 | 6.29 | 9.36 |
| Return On Assets (%) | 3.73 | 7.18 | 13.27 |
| Total Debt / Equity (X) | 0.32 | 0.31 | 0.25 |
| Asset Turnover Ratio (%) | 1.31 | 1.49 | 1.35 |
| Particulars | Mar 2025 |
|---|---|
| PBDIT Margin (%) | 9.59 |
| PBIT Margin (%) | 6.24 |
| PBT Margin (%) | 3.96 |
| Net PROFIT Margin (%) | 2.85 |
| Return On Networth / Equity (%) | 4.98 |
| Return On Networth /Employed (%) | 5.82 |
| Return On Assets (%) | 3.73 |
| Total Debt / Equity (X) | 0.32 |
| Asset Turnover Ratio (%) | 1.31 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Fixed Assets Annual | 58.78 | 41.98 | 41.73 |
| Total Current Assets Annual | 84.73 | 93.77 | 87.31 |
| Non Current Assets Annual | 66.90 | 53.91 | 42.27 |
| Total Shareholders Funds Annual | 84.81 | 80.84 | 73.45 |
| Total Assets Annual | 153.08 | 147.68 | 129.58 |
| Particulars | Mar 2025 |
|---|---|
| Fixed Assets Annual | 58.78 |
| Total Current Assets Annual | 84.73 |
| Non Current Assets Annual | 66.90 |
| Total Shareholders Funds Annual | 84.81 |
| Total Assets Annual | 153.08 |
EPS (INR)
Expected
0.00
Reported
-0.25
Surprise
0.00%
Jun 2019
EPS beaten by 0.00%
Sep 2018
EPS beaten by 0.00%
Jun 2018
EPS beaten by 0.00%
